Publications by authors named "William Ebling"

Claim this Profile
T
The use of roxifiban (DMP754), a novel oral platelet glycoprotein IIb/IIIa receptor inhibitor, in patients with stable coronary artery disease.
Joseph Murphy, R Scott Wright, Ihor Gussak, Brent Williams, Robert N Daly, William Ebling

Am J Cardiovasc Drugs· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation and implementation of drug-dependent antibody assays in clinical trials for safety monitoring of patients dosed with roxifiban, an orally bioavailable glycoprotein IIb/IIIa antagonist.
Yu Chen Barrett, William Ebling, Henry Pieniaszek, Jeffrey Billheimer, Dietmar Seiffert

J Pharm Biomed Anal· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective testing for drug-dependent antibodies reduces the incidence of thrombocytopenia observed with the small molecule glycoprotein IIb/IIIa antagonist roxifiban: implications for the etiology of thrombocytopenia.
Dietmar Seiffert, Andrew M Stern, William Ebling, Richard J Rossi, Yu Chen Barrett

Blood· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrated pharmacokinetic/pharmacodynamic model of XV459, a potent and specific GPIIb/IIIa inhibitor, in healthy male volunteers.
Michael J Fossler, William F Ebling, Su Ma, David Kornhauser, John Mondick

J Clin Pharmacol· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, pharmacokinetics, and time course of pharmacologic response of the active metabolite of roxifiban, XV459, a glycoprotein IIb/IIIa antagonist, following oral administration in healthy volunteers.
Henry J Pieniaszek, Sherwin K B Sy, William Ebling, Michael J Fossler, Valerie A Cain

J Clin Pharmacol· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis